BC is a highly heterogeneous and multifactorial disease that can be classified into four subtypes (Luminal A/B, human epidermal growth factor receptor 2 (HER2)-positive and triple-negative), based on the expression of the estrogen receptor (ER), progesterone receptor (PR) and HER2 [1,2]. This evidence concerns the gene PGR and breast cancer.